Comparison of genetic and health risk factors for mild cognitive impairment and Alzheimer's disease between Hispanic and non-Hispanic white participants

被引:3
作者
Xiao, Cally [1 ]
Pappas, Ioannis M. [1 ]
Aksman, Leon E. [1 ]
O'Bryant, Sid W. [1 ]
Toga, Arthur [1 ]
HABS HD Study Team [1 ]
Alzheimers Dis Neuroimaging Initiat [1 ]
机构
[1] Univ North Texas Hlth Sci Ctr, Inst Translat Res, Ft Worth, TX USA
基金
加拿大健康研究院; 美国国家卫生研究院;
关键词
Alzheimer's disease; apolipoprotein E; depression; hispanics; latinos; hypertension; mild cognitive impairment; stroke; APOLIPOPROTEIN-E; ASSOCIATION; DEPRESSION; AMERICANS;
D O I
10.1002/alz.13110
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
INTRODUCTIONThe influence of apolipoprotein E (APOE) genotype on mild cognitive impairment (MCI) and Alzheimer's disease (AD) is well studied in the non-Hispanic white (NHW) population but not in the Hispanic population. Additionally, health risk factors such as hypertension, stroke, and depression may also differ between the two populations. METHODSWe combined three data sets (National Alzheimer's Coordinating Center [NACC], Alzheimer's Disease Neuroimaging Initiative [ADNI], Health and Aging Brain Study: Health Disparities [HABS-HD]) and compared risk factors for MCI and AD between Hispanic and NHW participants, with a total of 24,268 participants (11.1% Hispanic). RESULTSAPOE epsilon 4 was associated with fewer all-cause MCI cases in Hispanic participants (Hispanic odds ratio [OR]: 1.114; NHW OR: 1.453), and APOE epsilon 2 (Hispanic OR: 1.224; NHW OR: 0.592) and depression (Hispanic OR: 2.817; NHW OR: 1.847) were associated with more AD cases in Hispanic participants. DISCUSSIONAPOE epsilon 2 may not be protective for AD in Hispanic participants and Hispanic participants with depression may face a higher risk for AD. HighlightsGAAIN allows for discovery of data sets to use in secondary analyses.APOE epsilon 2 was not protective for AD in Hispanic participants.APOE epsilon 4 was associated with fewer MCI cases in Hispanic participants.Depression was associated with more AD cases in Hispanic participants.
引用
收藏
页码:5086 / 5094
页数:9
相关论文
共 50 条
  • [41] Genome instability biomarkers and blood micronutrient risk profiles associated with mild cognitive impairment and Alzheimer's disease
    Lee, Sau Lai
    Thomas, Philip
    Fenech, Michael
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2015, 776 : 54 - 83
  • [42] Markers for the Risk of Progression from Mild Cognitive Impairment to Alzheimer's Disease
    Buratti, Laura
    Balestrini, Simona
    Altamura, Claudia
    Viticchi, Giovanna
    Falsetti, Lorenzo
    Luzzi, Simona
    Provinciali, Leandro
    Vernieri, Fabrizio
    Silvestrini, Mauro
    JOURNAL OF ALZHEIMERS DISEASE, 2015, 45 (03) : 883 - 890
  • [43] White matter hyperintensities and neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's disease
    Misquitta, Karen
    Dadar, Mahsa
    Collins, D. Louis
    Tartaglia, Maria Carmela
    NEUROIMAGE-CLINICAL, 2020, 28
  • [44] Alzheimer's disease risk variants modulate endophenotypes in mild cognitive impairment
    Louwersheimer, Eva
    Wolfsgruber, Steffen
    Espinosa, Ana
    Lacour, Andre
    Heilmann-Heimbach, Stefanie
    Alegret, Montserrat
    Hernandez, Isabel
    Rosende-Roca, Maitee
    Tarraga, Lluis
    Boada, Merce
    Kornhuber, Johannes
    Peters, Oliver
    Frolich, Lutz
    Hull, Michael
    Ruther, Eckart
    Wiltfang, Jens
    Scherer, Martin
    Riedel-Heller, Steffi
    Jessen, Frank
    Nothen, Markus M.
    Maier, Wolfgang
    Koene, Ted
    Scheltens, Philip
    Holstege, Henne
    Wagner, Michael
    Ruiz, Agustin
    van der Flier, Wiesje M.
    Becker, Tim
    Ramirez, Alfredo
    ALZHEIMERS & DEMENTIA, 2016, 12 (08) : 872 - 881
  • [45] Non-invasive biomarkers for mild cognitive impairment and Alzheimer's disease
    Botello-Marabotto, Marina
    Martinez-Bisbal, M. Carmen
    Calero, Miguel
    Bernardos, Andrea
    Pastor, Ana B.
    Medina, Miguel
    Martinez-Manez, Ramon
    NEUROBIOLOGY OF DISEASE, 2023, 187
  • [46] Genetic propensity for cerebral amyloidosis and risk of mild cognitive impairment and Alzheimer's disease within a cognitive reserve framework
    Mourtzi, Niki
    Charisis, Sokratis
    Tsapanou, Angeliki
    Ntanasi, Eva
    Hatzimanolis, Alexandros
    Ramirez, Alfredo
    Heilmann-Heimbach, Stefanie
    Grenier-Boley, Benjamin
    Lambert, Jean-Charles
    Yannakoulia, Mary
    Kosmidis, Mary
    Dardiotis, Efthimios
    Hadjigeorgiou, Georgiios
    Sakka, Paraskevi
    Georgakis, Marios
    Yaakov, Stern
    Scarmeas, Nikolaos
    ALZHEIMERS & DEMENTIA, 2023, 19 (09) : 3794 - 3805
  • [47] Assessment of White Matter Tract Damage in Mild Cognitive Impairment and Alzheimer's Disease
    Pievani, Michela
    Agosta, Federica
    Pagani, Elisabetta
    Canu, Elisa
    Sala, Stefania
    Absinta, Martina
    Geroldi, Cristina
    Ganzola, Rossana
    Frisoni, Giovanni B.
    Filippi, Massimo
    HUMAN BRAIN MAPPING, 2010, 31 (12) : 1862 - 1875
  • [48] Motor timing intraindividual variability in amnestic mild cognitive impairment and cognitively intact elders at genetic risk for Alzheimer's disease
    Kay, Christina D.
    Seidenberg, Michael
    Durgerian, Sally
    Nielson, Kristy A.
    Smith, J. Carson
    Woodard, John L.
    Rao, Stephen M.
    JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY, 2017, 39 (09) : 866 - 875
  • [49] Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment
    Lacour, A.
    Espinosa, A.
    Louwersheimer, E.
    Heilmann, S.
    Hernandez, I.
    Wolfsgruber, S.
    Fernandez, V.
    Wagner, H.
    Rosende-Roca, M.
    Mauleon, A.
    Moreno-Grau, S.
    Vargas, L.
    Pijnenburg, Y. A. L.
    Koene, T.
    Rodriguez-Gomez, O.
    Ortega, G.
    Ruiz, S.
    Holstege, H.
    Sotolongo-Grau, O.
    Kornhuber, J.
    Peters, O.
    Froelich, L.
    Huell, M.
    Ruether, E.
    Wiltfang, J.
    Scherer, M.
    Riedel-Heller, S.
    Alegret, M.
    Noethen, M. M.
    Scheltens, P.
    Wagner, M.
    Tarraga, L.
    Jessen, F.
    Boada, M.
    Maier, W.
    van der Flier, W. M.
    Becker, T.
    Ramirez, A.
    Ruiz, A.
    MOLECULAR PSYCHIATRY, 2017, 22 (01) : 153 - 160
  • [50] Risk Classification in Mild Cognitive Impairment Patients for Developing Alzheimer's Disease
    Zhou, Bin
    Nakatani, Eiji
    Teramukai, Satoshi
    Nagai, Yoji
    Fukushima, Masanori
    JOURNAL OF ALZHEIMERS DISEASE, 2012, 30 (02) : 367 - 375